M
Mónika Vastag
Publications - 52
Citations - 1035
Mónika Vastag is an academic researcher. The author has contributed to research in topics: Blood–brain barrier & Allosteric regulation. The author has an hindex of 16, co-authored 49 publications receiving 854 citations.
Papers
More filters
Journal ArticleDOI
Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models
Éva Hellinger,Szilvia Veszelka,Andrea E. Tóth,Fruzsina R. Walter,Ágnes Kittel,Mónika L Bakk,Károly Tihanyi,Viktor Háda,Shinsuke Nakagawa,Thuy Dinh Ha Duy,Masami Niwa,Mária A. Deli,Mónika Vastag +12 more
TL;DR: While the complexity and predictive value of the BBB model is the highest, for the screening of NCEs to determine whether they are efflux substrates or not, the VB-Caco-2 and the MDCK-MDR1 models may provide a simple and inexpensive tool.
Journal ArticleDOI
Comparison of a Rat Primary Cell-Based Blood-Brain Barrier Model With Epithelial and Brain Endothelial Cell Lines: Gene Expression and Drug Transport
Szilvia Veszelka,András Tóth,András Tóth,Fruzsina R. Walter,Andrea E. Tóth,Ilona Gróf,Ilona Gróf,Mária Mészáros,Mária Mészáros,Alexandra Bocsik,Éva Hellinger,Mónika Vastag,Gábor Rákhely,Gábor Rákhely,Mária A. Deli +14 more
TL;DR: Among the tested culture models, the primary cell-based EPA model is suitable for the functional analysis of the BBB and the absence of gene expression of important BBB efflux and influx transporters BCRP, MRP6, MCT6, -8, PHT2, OATPs in one or both types of epithelial models suggests that Caco-2 or MDCK models are not suitable to test drug candidates which are substrates of these transporter.
Journal ArticleDOI
Discovery of cariprazine (RGH-188): a novel antipsychotic acting on dopamine D3/D2 receptors.
Éva Ágai-Csongor,György Domány,Katalin Nogradi,Janos Galambos,Istvan Vago,György M. Keserű,István Greiner,István Laszlovszky,Aniko Gere,Eva Schmidt,Bela Kiss,Mónika Vastag,Károly Tihanyi,Katalin Saghy,Judit Laszy,Istvan Gyertyan,Mária Zájer-Balázs,Larisza Gémesi,Margit Kapás,Zsolt Szombathelyi +19 more
TL;DR: Medicinal chemistry optimization of an impurity isolated during the scale-up synthesis of a pyridylsulfonamide type dopamine D(3)/D(2) compound led to a series of new piperazine derivatives having affinity to both dopamine D3 and D2 receptors.
Journal ArticleDOI
Reversible Opening of Intercellular Junctions of Intestinal Epithelial and Brain Endothelial Cells With Tight Junction Modulator Peptides
Alexandra Bocsik,Alexandra Bocsik,Fruzsina R. Walter,Andrea Gyebrovszki,Lívia Fülöp,Ingolf E. Blasig,Sebastian Dabrowski,Ferenc Ötvös,András Tóth,Gábor Rákhely,Szilvia Veszelka,Mónika Vastag,Piroska Szabó-Révész,Mária A. Deli +13 more
TL;DR: The results indicate that these peptides can be effectively and selectively used as potential pharmaceutical excipients to improve drug delivery across biological barriers.
Journal Article
Current in vitro and in silico models of blood-brain barrier penetration: a practical view.
Mónika Vastag,György M. Keserü +1 more
TL;DR: This review gives a practical summary of in vitro and in silico approaches to evaluate BBB penetration, with models that provide sufficient predictivity, reliability and throughput to be favored by the pharmaceutical industry.